RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business... Show more
RXO stock has navigated volatile trading in recent weeks, reflecting broader freight sector pressures from softening truckload demand and capacity shifts. Shares experienced sharp declines following Q3 earnings, which highlighted margin compression despite revenue growth, but have shown partial recovery amid cost-saving announcements. The asset-light brokerage model continues to benefit from strong less-than-truckload and last-mile momentum, offsetting full-truckload weakness. Trading near the lower end of its 52-week range with elevated beta, RXO remains sensitive to industry cycles, with investor focus on Q4 guidance and early 2026 recovery signals.
RXO's stock has faced downward pressure in recent trading sessions, primarily triggered by its November 6, 2025, Q3 earnings release, which revealed adjusted EPS of $0.01—far below the expected $0.25—prompting a pre-market drop of over 12%. Revenue climbed to $1.4 billion from $1.0 billion year-over-year, fueled by brokerage volume up 1%, with less-than-truckload surging 43% to comprise a larger mix, though full-truckload fell 11% amid persistent demand softness. Brokerage gross margins slipped to 13.5%, reflecting higher purchased transportation costs and tightening capacity seen late in the quarter.
Q4 guidance intensified selling, forecasting adjusted EBITDA of $20-30 million, brokerage gross margins of 12-13%, and low-single-digit volume declines, as truckload market tightness—driven by carrier exits and regulatory scrutiny on drivers—pressures profitability without demand rebound. Management highlighted new cost initiatives targeting over $30 million in annualized savings through productivity gains and restructuring, partially mitigating headwinds.
Analyst reactions were mixed: Truist lowered its price target to $18 from $20 on January 15, 2026, citing margin risks but retaining Buy; Benchmark held Neutral amid brokerage pressures; Wolfe upgraded to Peer Perform post-55% YTD decline; Morgan Stanley shifted to Overweight at $19, viewing the selloff as a valuation opportunity. Consensus remains Hold, with targets averaging $16.
Positive offsets include Coyote Logistics integration ahead of schedule since its September 2024 close, boosting scale to third-largest U.S. broker with expanded carrier network and synergies exceeding expectations. Last Mile delivery posted 12% stop growth, and Managed Transportation grew its pipeline. Macro factors like decelerating spot rates (1.8% YoY in Q3) and fragile capacity add volatility, but potential Fed cuts could aid manufacturing freight. Overall, price action links directly to freight cycle woes, tempered by operational resilience.
As RXO enters 2026, attention centers on truckload market recovery amid ongoing capacity rationalization, including declining Class 8 orders and stricter driver regulations that could tighten supply further. Analysts project FY2026 EPS at $0.12, up from FY2025's -$0.01, assuming demand inflection and cost synergies realization. Full Coyote integration promises enhanced network density, diversified verticals, and at least $50 million in annualized synergies, bolstering scale advantages.
Investors should track LTL and Last Mile momentum, which have shown resilience with double-digit growth, alongside brokerage margin expansion from $30+ million cost savings and AI-driven tools like spot quoting. Risks include prolonged freight softness, trade policy shifts, and macroeconomic drags on manufacturing PMI. Opportunities lie in potential rate normalization if capacity exits persist and interest rate cuts spur volumes. Competitive positioning via RXO Connect platform and $2 billion Managed Transportation pipeline will be pivotal for capturing share in a cyclical rebound.
RXO saw its Momentum Indicator move above the 0 level on May 18, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 54 similar instances where the indicator turned positive. In of the 54 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for RXO just turned positive on May 20, 2026. Looking at past instances where RXO's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXO advanced for three days, in of 212 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 168 cases where RXO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for RXO moved out of overbought territory on June 12, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
RXO broke above its upper Bollinger Band on May 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RXO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.099) is normal, around the industry mean (3.799). RXO's P/E Ratio (670.667) is considerably higher than the industry average of (166.863). RXO's Projected Growth (PEG Ratio) (189.000) is slightly higher than the industry average of (39.668). RXO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.010). P/S Ratio (0.834) is also within normal values, averaging (2.156).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Trucking